Aduro Biotech

YTD

ALL

Why Robinhood?

You can watch Aduro Biotech and buy or sell other stocks, options, and ETFs commission-free!

About ADRO

Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes.

CEO

Stephen T. Isaacs

CEOStephen T. Isaacs

Employees

214

Employees214

Headquarters

Berkeley, California

HeadquartersBerkeley, California

Founded

2008

Founded2008

Employees

214

Employees214

ADRO Key Statistics

Market cap

955.55M

Market cap955.55M

Price-Earnings ratio

-7.50

Price-Earnings ratio-7.50

Dividend yield

—

Dividend yield—

Average volume

422.35K

Average volume422.35K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$27.44

52 Week high$27.44

52 Week low

$12.41

52 Week low$12.41